微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日,Nevro公司宣布,其专有的10 kHZ脊髓刺激(SCS)“Senza”系统,已获得美国FDA批准,用于治疗疼痛性糖尿病神经病变(PDN)引起的慢性疼痛。新闻稿指出,这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准,推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ CT ORDER - Confidential treatment order Filed: 2016-04-20 AccNo: 9999999997-16-022391 Size: 14 KB 网页链接
$Nevro(NVRO)$ 美东时间 2016-05-18 13:30 Nevro Corp Annual Shareholders Meeting 网页链接
$Nevro(NVRO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-06 AccNo: 0001193125-16-532264 Size: 376 KB 网页链接
$Nevro(NVRO)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-06 AccNo: 0001193125-16-532256 Size: 702 KB 网页链接
$Nevro(NVRO)$ 内部交易: 2016-04-04,VP of Sales & Marketing,Enxing Michael ,卖出,8767普通股, $61.59
$Nevro(NVRO)$ 内部交易: 2016-04-04,VP of Sales & Marketing,Enxing Michael ,期权,8767普通股, $3.60
$Nevro(NVRO)$ 美东时间 2016-05-27 12:30 Nevro Corp Annual Shareholders Meeting (Estimated) 网页链接
$Nevro(NVRO)$ 8-K - Current report Filed: 2016-03-15 AccNo: 0001193125-16-505329 Size: 15 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Nevro(NVRO)$ 内部交易: 2016-12-29,总裁,Elghandour Rami ,期权,485普通股, $3.60
$Nevro(NVRO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-03-04 AccNo: 0001144204-16-086100 Size: 85 KB 网页链接